Charles S. Berkman, SVP, General Counsel & Secretary at LIGAND PHARMACEUTICALS INC (LGND), sold 22,292 shares at $118.59 ($2.6M) on 2020-06-04, disclosed to the SEC on 2020-06-05.
Open-market sale of $2.6M LGND by SVP, General Counsel & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.59 | 11,146 | $1.3M | 50.0% |
| 2 | $118.59 | 11,146 | $1.3M | 50.0% |
| Total | $118.59 avg | 22,292 | $2.6M | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $12K | — | Filing → |
| OABI | SELL | 2025-12-09 | $16K | — | Filing → |
| OABI | SELL | 2025-04-07 | $14K | — | Filing → |